146 related articles for article (PubMed ID: 23834440)
21. A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Vervaeke S; Vandamme K; Boone E; De Laere E; Swinne D; Surmont I
Med Mycol; 2008 Dec; 46(8):853-6. PubMed ID: 18798049
[TBL] [Abstract][Full Text] [Related]
22.
Maccaro A; Pascale R; Liberatore A; Turello G; Ambretti S; Viale P; Cricca M
Med Mycol Case Rep; 2021 Sep; 33():5-8. PubMed ID: 34168955
[No Abstract] [Full Text] [Related]
23. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
[TBL] [Abstract][Full Text] [Related]
24. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Khan ZU; Al-Sweih NA; Ahmad S; Al-Kazemi N; Khan S; Joseph L; Chandy R
J Clin Microbiol; 2007 Jun; 45(6):2025-7. PubMed ID: 17428940
[TBL] [Abstract][Full Text] [Related]
25. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):278-83. PubMed ID: 20846808
[TBL] [Abstract][Full Text] [Related]
26. Incidence and antifungal susceptibility of Candida species in neonatal septicemia.
Vinod Kumar CS; Neelagund YF
J Commun Dis; 2004 Sep; 36(3):182-6. PubMed ID: 16509255
[TBL] [Abstract][Full Text] [Related]
27. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
28. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
29. Two cases of fungemia due to Candida lusitaniae and a literature review.
Viudes A; Pemán J; Cantón E; Salavert M; Ubeda P; López-Ribot JL; Gobernado M
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):294-9. PubMed ID: 12072941
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
31. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
32. Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Giusiano G; Mangiaterra M; Saito VG; Rojas F; Gómez V; Díaz MC
Mycoses; 2006 Jan; 49(1):49-54. PubMed ID: 16367819
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary infection due to Pseudozyma aphidis in a patient with Burkitt lymphoma: first case report.
Parahym AM; da Silva CM; Domingos Ide F; Gonçalves SS; Rodrigues Mde M; de Morais VL; Neves RP
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):104-6. PubMed ID: 23182077
[TBL] [Abstract][Full Text] [Related]
35. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
36. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility.
Arendrup MC; Fuursted K; Gahrn-Hansen B; Schønheyder HC; Knudsen JD; Jensen IM; Bruun B; Christensen JJ; Johansen HK
Clin Microbiol Infect; 2008 May; 14(5):487-94. PubMed ID: 18294241
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].
Pemán J; Cantón E; Miñana JJ; Florez JA; Echeverria J; Ortega DN; Alarcón JM; Fontanals D; Sard BG; Moreno BB; Torroba L; Ayats J; Pérez MÁ; Fernández MA; Reus FS; Natal IF; García GR; Ezpeleta G; Martín-Mazuelos E; Iglesias I; Rezusta A; de Ocariz IR; Nieto AG;
Rev Iberoam Micol; 2011; 28(2):91-9. PubMed ID: 21376831
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
39. Malassezia pachydermatis fungaemia in a neonatal intensive care unit.
Chryssanthou E; Broberger U; Petrini B
Acta Paediatr; 2001 Mar; 90(3):323-7. PubMed ID: 11332175
[TBL] [Abstract][Full Text] [Related]
40. [Blastoschizomyces capitatus fungemia: three case reports and review of the literature].
Gültekin B; Yavaşoğlu I; Eyigör M; Kadıköylü G; Bolaman Z; Aydın N
Mikrobiyol Bul; 2012 Jan; 46(1):134-43. PubMed ID: 22399183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
